Back to Search
Start Over
HTLV-1 seropositive patients with lung cancer treated with PD-1 inhibitors.
- Source :
-
Cancer science [Cancer Sci] 2020 Sep; Vol. 111 (9), pp. 3395-3396. Date of Electronic Publication: 2020 Jul 18. - Publication Year :
- 2020
- Subjects :
- Aged
Antibodies, Monoclonal, Humanized adverse effects
Asymptomatic Infections
Carcinoma, Non-Small-Cell Lung drug therapy
Carcinoma, Non-Small-Cell Lung immunology
Carrier State blood
Carrier State immunology
Carrier State virology
Follow-Up Studies
HTLV-I Antibodies blood
HTLV-I Antibodies immunology
HTLV-I Infections chemically induced
HTLV-I Infections immunology
HTLV-I Infections virology
Human T-lymphotropic virus 1 isolation & purification
Humans
Lung Neoplasms drug therapy
Lung Neoplasms immunology
Male
Middle Aged
Nivolumab adverse effects
Programmed Cell Death 1 Receptor immunology
Retrospective Studies
Antineoplastic Agents, Immunological adverse effects
Carrier State diagnosis
HTLV-I Infections diagnosis
Human T-lymphotropic virus 1 immunology
Programmed Cell Death 1 Receptor antagonists & inhibitors
Subjects
Details
- Language :
- English
- ISSN :
- 1349-7006
- Volume :
- 111
- Issue :
- 9
- Database :
- MEDLINE
- Journal :
- Cancer science
- Publication Type :
- Report
- Accession number :
- 32557883
- Full Text :
- https://doi.org/10.1111/cas.14536